Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1247.2000 27.10 (2.22%)
NSE Apr 28, 2025 15:31 PM
Volume: 1.1M
 

1247.20
2.22%
KRChoksey
Aurobindo Pharma’s revenue beat our estimates (+2.8%) due to strong performance in Europe and Growth markets. EBITDA beat our estimates (+4.4%) due to better than expected gross profit and Adj. PAT beat our estimates due to better than expected other income and lower than expected tax expense.
Aurobindo Pharma Ltd. is trading above its 100 day SMA of 1183.2
More from Aurobindo Pharma …
All earning calls
Investor presentations from Aurobindo Pharma …
All investor presentations